# LAMax Vs. Watchman LAAC Device for Subjects With Non-valvular AF to Reduce the Risk of Stroke

> **NCT04429646** · NA · COMPLETED · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 236 (actual)

## Conditions studied

- Non-valvular Atrial Fibrillation

## Interventions

- **DEVICE:** Percutaneous left atrial appendage closure-LAMax
- **DEVICE:** Percutaneous left atrial appendage closure-Watchman

## Key facts

- **NCT ID:** NCT04429646
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-20
- **Primary completion:** 2020-11-11
- **Final completion:** 2021-06-10
- **Target enrollment:** 236 (ACTUAL)
- **Last updated:** 2022-05-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04429646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04429646, "LAMax Vs. Watchman LAAC Device for Subjects With Non-valvular AF to Reduce the Risk of Stroke". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04429646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*